info@seagull-health.com
SeagullHealth
语言:
search
new
How to Purchase Triumeq
501
Article source: Seagull Pharmacy
Nov 05, 2025

Triumeq (Abacavir, Dolutegravir and Lamivudine Tablets) is a fixed-dose combination preparation used for the treatment of HIV-1 infection, containing three active ingredients: abacavir, dolutegravir, and lamivudine. As a prescription medication, obtaining it correctly and ensuring its authenticity are of great importance for treatment efficacy and patient safety.

How to Purchase Triumeq

Overseas Purchase

Patients may choose to consult and purchase Triumeq at hospital pharmacies or regular drugstores in countries or regions where the medication has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase through Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions can usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Triumeq

Genetic Testing Must Be Conducted Before Use

Abacavir, one of the components in Triumeq, may cause severe allergic reactions, and this risk is closely associated with the HLA-B*5701 genotype.

Before initiating treatment, doctors must arrange HLA-B*5701 allele screening for patients.

If the test result is positive or the patient has a history of allergy to abacavir, the use of this product is strictly prohibited.

Assessment of Hepatitis B Infection Status

All HIV-infected patients should undergo hepatitis B virus (HBV) testing before using Triumeq.

If the patient has concurrent hepatitis B infection, unauthorized discontinuation of Triumeq may lead to severe acute exacerbation of hepatitis B.

When necessary, concurrent anti-hepatitis B treatment should be administered, and the entire treatment course should be managed under the guidance of a doctor.

Attention to Dosage Form Differences

Triumeq is available in two dosage forms: regular tablets and oral suspension tablets (PD dosage form), which are suitable for adults and children of different body weights respectively.

The two dosage forms cannot be replaced equivalently by milligram (mg) content. During purchase and use, the dosage form must be strictly verified to avoid misuse.

Caution Regarding Drug Interactions

Triumeq has interactions with a variety of drugs. For example, concurrent use with dofetilide is contraindicated, and dosage adjustments are required when used together with certain anticonvulsants, rifampicin, etc.

When visiting a doctor, patients should proactively inform the doctor of all medications they are currently using, including prescription drugs, over-the-counter drugs, and health supplements.

How to Identify the Authenticity of Triumeq

Inspect the Drug Packaging

The outer packaging of authentic Triumeq has clear printing, bright colors, and no blurred or overlapping text.

The packaging box should clearly display information such as the batch number, expiration date, and manufacturer (ViiV Healthcare).

A desiccant is usually included in the bottle, and the bottle cap is equipped with a child-resistant closure.

Verify the Drug Appearance

Triumeq regular tablets: Purple, oval, biconvex film-coated tablets, engraved with "572Tri" on one side.

Triumeq PD oral suspension tablets: Yellow, capsule-shaped, biconvex tablets with a strawberry cream flavor, engraved with "SVWTU" on one side.

If the color, shape, or engraved text of the tablets does not match the above description, or if the tablets are damaged, deliquescent, or have an unusual odor, they should be highly suspected of being counterfeit.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of Riociguat Tablets (Adempas)?
Riociguat Tablets (Adempas) demonstrate significant value in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). As a targeted therapeutic...
Precautions for the Administration of Riociguat Tablets (Adempas)
Riociguat Tablets (Adempas), as a soluble guanylate cyclase stimulant, hold an important position in the treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension....
How to Use Riociguat Tablets (Adempas)
Riociguat Tablets (Adempas) are a soluble guanylate cyclase (sGC) stimulant, used for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) i...
Indications for Riociguat Tablets (Adempas)
As a soluble guanylate cyclase (sGC) stimulant, Riociguat Tablets (Adempas) provide an innovative therapeutic option for the treatment of specific types of pulmonary arterial hypertension.Indications ...
Indications for Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection. It consists of three active ingredients: abacavir, dolutegravir, and la...
Administration of Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection.Administration of TriumeqAdult DosageThe recommended dose is one tablet ...
How to Purchase 想Tablets (Azithromycin)
Azithromycin Tablets (Azithromycin) are a commonly used macrolide antib iotic that plays an important role in the treatment of various bacterial infections.How to Purchase Azithromycin Tablets (Azithr...
Indications for Fingolimod (Fingolimod)
Fingolimod is a sphingosine-1-phosphate receptor modulator, mainly used for the treatment of relapsing multiple sclerosis. Since it was first approved in the United States in 2010, it has become one o...
Related Articles
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option for patients with estrogen receptor-positive, HER2-negative advanced or metastatic ...
What Are the Indications for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of advanced breast cancer with specific gene mutations. As an estrogen receptor antagonist...
What Are the Purchase Channels for Elacestrant (Orserdu)?
With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific gene mutations, has brought new treatment options for patients. As the first oral sel...
Adverse Reactions of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced non-small cell lung cancer harboring MET gene mutations. By precisely inhibiting the act...
What are the Precautions for Capmatinib (Tabrecta) Administration?
Capmatinib (Tabrecta) is a targeted therapy drug for MET gene mutations, demonstrating significant efficacy in the treatment of advanced malignancies such as non-small cell lung cancer.What are the Pr...
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved